Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Royal Gold
RGLD
$19.5B
| $2.21M | ﹤0.01% |
19,569
-1,553
| -7% | -$160K |
|
2152
Community Bank
CBU
$3.41B
| $2.2M | ﹤0.01% |
35,011
+10,129
| +41% | +$633K |
|
2153
iShares MSCI Switzerland ETF
EWL
$2.23B
| $2.2M | ﹤0.01% |
52,478
-185
| -0.4% | -$7.53K |
|
|
EHAB
2154
DELISTED
Enhabit
EHAB
| $2.2M | ﹤0.01% |
167,085
+140,383
| +526% | +$1.87M |
|
2155
Wingstop
WING
$3.18B
| $2.2M | ﹤0.01% |
15,977
+5,069
| +46% | +$748K |
|
2156
Steven Madden
SHOO
$3.55B
| $2.2M | ﹤0.01% |
68,729
+4,567
| +7% | +$143K |
|
2157
Simpson Manufacturing
SSD
$8.16B
| $2.2M | ﹤0.01% |
24,773
+11,673
| +89% | +$1.02M |
|
2158
Regenxbio
RGNX
$708M
| $2.19M | ﹤0.01% |
96,608
+11,463
| +13% | +$259K |
|
2159
Turning Point Brands
TPB
$1.74B
| $2.19M | ﹤0.01% |
101,156
-23,047
| -19% | -$490K |
|
|
ARNC
2160
DELISTED
Arconic Corporation
ARNC
| $2.19M | ﹤0.01% |
103,287
+56,184
| +119% | +$1.17M |
|
2161
Spire
SR
$4.85B
| $2.18M | ﹤0.01% |
31,669
-4,288
| -12% | -$292K |
|
|
BRSL
2162
Brightstar Lottery PLC
BRSL
$2.03B
| $2.18M | ﹤0.01% |
96,019
-73,837
| -43% | -$1.6M |
|
2163
iShares Global Healthcare ETF
IXJ
$4.18B
| $2.18M | ﹤0.01% |
+25,640
| New | +$2.11M |
|
2164
Oxford Industries
OXM
$552M
| $2.17M | ﹤0.01% |
23,308
-2,291
| -9% | -$229K |
|
2165
CALL
Sibanye-Stillwater
SBSW
$7.53B
| $2.17M | ﹤0.01% |
+203,600
| New | +$2.07M |
|
2166
Texas Capital Bancshares
TCBI
$4.32B
| $2.17M | ﹤0.01% |
35,983
+17,041
| +90% | +$1.01M |
|
2167
Bank OZK
OZK
$5.61B
| $2.15M | ﹤0.01% |
53,785
+5,720
| +12% | +$246K |
|
2168
Jackson Financial
JXN
$8.8B
| $2.15M | ﹤0.01% |
61,912
-7,446
| -11% | -$259K |
|
|
SGFY
2169
DELISTED
Signify Health, Inc.
SGFY
| $2.15M | ﹤0.01% |
75,143
-17,176
| -19% | -$496K |
|
|
ACLX
2170
DELISTED
Arcellx
ACLX
| $2.15M | ﹤0.01% |
69,322
+10,285
| +17% | +$236K |
|
2171
CALL
EPR Properties
EPR
$4.77B
| $2.15M | ﹤0.01% |
+56,900
| New | +$2.21M |
|
|
CHX
2172
DELISTED
ChampionX
CHX
| $2.14M | ﹤0.01% |
73,928
+37,200
| +101% | +$1.03M |
|
2173
CALL
Qorvo
QRVO
$8.74B
| $2.14M | ﹤0.01% |
+23,600
| New | +$2.13M |
|
2174
Yelp
YELP
$1.41B
| $2.14M | ﹤0.01% |
78,109
+41,720
| +115% | +$1.32M |
|
|
SASR
2175
DELISTED
Sandy Spring Bancorp Inc
SASR
| $2.13M | ﹤0.01% |
60,452
+4,190
| +7% | +$147K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.